Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
Clinical trial NCT01555892 · RECRUITING
Trial details
- NCT number
- NCT01555892
- Sponsor
- Baylor College of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-14
- Primary completion
- 2027-03-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.